Shan K. Naidu

1.2k citations
22 papers · 533 indexed · h-index 14

Shan K. Naidu

22 papers receiving 529 citations

Peers

Shan K. Naidu
Comparison fields: 5 of 74
  • Cancer Research 95
  • Oncology 167
  • Molecular Medicine 25
  • Molecular Biology 290
  • Toxicology 13
Replace Kamila Wolanin with:
Kamila Wolanin Poland
Stacey Fossey United States
Yung‐Kwei Soong Taiwan
Rukh Yusuf United States
Hardik Mody United States
Siti‐Faujiah Hendrayani Saudi Arabia
Helga Weber Chile
Deborah Chirnomas United States
Leping Yang China
Zhenfeng Guan China
Shan K. Naidu relative to Kamila Wolanin Poland Kamila Wolanin's profile →
Citations per field
00.5×1.5×2.2×
Kamila Wolanin · 1×
Citations per year

Countries citing papers authored by Shan K. Naidu

Since Specialization
Citations

This map shows the geographic impact of Shan K. Naidu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan K. Naidu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan K. Naidu more than expected).

Fields of papers citing papers by Shan K. Naidu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan K. Naidu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan K. Naidu. The network helps show where Shan K. Naidu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shan K. Naidu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shan K. Naidu Line = papers co-authored together Shan K. Naidu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20225
2 202026
3 201910
4 201817
5 20183
6 20189
7 201716
8 20179
9 201617
10 201476
11 201453
12 201418
13 201413
14 201323
15 20123
16
Abstract 16618: Pharmacological Modulation of PTEN Ameliorates the Progression of Pulmonary Hypertension in Heart Failure
20111
17 201135
18 201137
19 201054
20 200874

About Shan K. Naidu

Shan K. Naidu is a scholar working on Virology, Oncology and Toxicology, having authored 22 papers that have together received 533 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Herpesvirus Infections and Treatments (3 papers), Cancer-related Molecular Pathways (3 papers), Cancer Mechanisms and Therapy (2 papers), Respiratory viral infections research (2 papers), Protein Tyrosine Phosphatases (2 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Cancer Research (95 citations), Oncology (167 citations) and Molecular Medicine (25 citations). Shan K. Naidu has collaborated with scholars based in United States, Hungary and France. Frequent co-authors include Periannan Kuppusamy, Karuppaiyah Selvendiran, Mahmood Khan, Kálmán Hideg, David E. Cohn, M. Lakshmi Kuppusamy, Gustavo Leone, Brian K. Rivera, Sarath Meduru and Georgia A. McCann. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026